We summarize here the results of the TARC experiment whose main purpose is to demonstrate the possibility of using Adiabatic Resonance Crossing (ARC) to destroy efficiently Long-Lived Fission Fragments (LLFFs) in accelerator-driven systems and to validate a new simulation developed in the framework of the Energy Amplifier programme. An experimental set-up was installed in a CERN PS proton beam line to study how neutrons produced by spallation at relatively high energy ( E n ≥ 1 MeV) slow down quasi adiabatically with almost flat isolethargic energy distribution and reach the capture resonance energy of an element to be transmuted where they will have a high probability of being captured. Precision measurements of energy and space distributions of spallation neutrons (using 2.5 GeV/ c and 3.5 GeV/ c protons) slowing down in a 3.3 m × 3.3 m × 3 m lead volume and of neutron capture rates on LLFFs 99 Tc, 129 I, and several other elements were performed. An appropriate formalism and appropriate computational tools necessary for the analysis and understanding of the data were developed and validated in detail. Our direct experimental observation of ARC demonstrates the possibility to destroy, in a parasitic mode, outside the Energy Amplifier core, large amounts of 99 Tc or 129 I at a rate exceeding the production rate, thereby making it practical to reduce correspondingly the existing stockpile of LLFFs. In addition, TARC opens up new possibilities for radioactive isotope production as an alternative to nuclear reactors, in particular for medical applications, as well as new possibilities for neutron research and industrial applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.